Featured Research

from universities, journals, and other organizations

Parasite Or Partner? Study Suggests New Role For Junk DNA

Date:
May 15, 2002
Source:
University Of Michigan Health System
Summary:
Junk DNA is the Rodney Dangerfield of the genetics world. It makes up nearly half of all human DNA, but many scientists dismiss it as useless gibberish. A new study published online today from the June 2002 issue of Nature Genetics, however, suggests that segments of junk DNA called LINE-1 elements deserve more respect.

ANN ARBOR, Mich. – Junk DNA is the Rodney Dangerfield of the genetics world. It makes up nearly half of all human DNA, but many scientists dismiss it as useless gibberish. A new study published online today from the June 2002 issue of Nature Genetics, however, suggests that segments of junk DNA called LINE-1 elements deserve more respect.

Conducted by scientists from the University of Michigan Medical School and Louisiana State University, the study is the first to show in mammalian cells that some human LINE-1, or L1, elements can jump to chromosomes with broken strands of DNA, slip into the break and repair the damage.

“Transposable L1 elements make up 17 percent of our DNA, but very little is known about them,” says John V. Moran, Ph.D., an assistant professor of human genetics and internal medicine in the U-M Medical School, who developed the first assay to identify mobile L1s in the human and mouse genomes. “Until now, everyone thought L1s were just intracellular parasites in our DNA – leftovers from the distant evolutionary past. The big question in the field is: Are they still there because we can’t get rid of them or do they have a function?”

L1s “reproduce” by using RNA and a process called reverse transcription to make complementary DNA copies of themselves, which can jump into other DNA sequences. Normally, L1s use an enzyme called endonuclease to cut the genetic DNA and create a space, so they can plug themselves into the genome.

“We knew about the endonuclease pathway,” says Tammy A. Morrish, a U-M graduate student in human genetics and first author of the paper. “But we didn’t know there was another mechanism that didn’t require endonuclease, or that L1s could jump into existing breaks in DNA.”

Morrish tested human L1s’ ability to repair DNA breaks in several normal and DNA-repair mutant cell lines derived from Chinese hamster ovary cells. Other researchers had demonstrated the ability of human L1s to repair DNA breaks in yeast cells, but Morrish is the first to show the effect can occur in mammalian cells.

Since DNA damage may lead to cell death unless it is repaired, the existence of an alternate repair pathway could be a good thing for the host cell. The question is, what’s in it for the L1?

“This study brings up the question of whether L1s are just taking advantage of DNA breaks to plug themselves into these sites or are they are being used by the host cell to mediate the repair,” says Moran. “From the L1s’ point of view, this gives it an alternate way of integrating into the DNA.”

Because L1s are so ancient and because they sometimes carry segments of genes with them when they jump to a new location, Moran believes they have played an important role in human evolution by increasing genetic diversity. He is one of only a few scientists to study L1s in the human genome.

“We have more transposable L1s in the human genome than any other species, but we know the least about where and how they move in humans,” says Moran. “We are here today either because of, or in spite of, L1s.”

In future research, Moran’s research team will examine whether it is possible to direct L1s to repair specific breaks in DNA, whether L1s can be used as vectors to deliver genetic material to specific DNA locations, and the impact of an L1 insertion on genes.

U-M researchers in the study were supported by the William M. Keck Foundation and the National Institutes of Health. Nicholas Gilbert, Ph.D., a U-M post-doctoral fellow in human genetics, collaborated in the study. Other collaborators included Mark A. Batzer, Jeremy S. Myers, and Bethaney J. Vincent from Louisiana State University; Thomas D. Stamato from Lankenau Institute for Medical Research in Wynnewood, Penn.; and Guillermo E. Taccioli from Boston University’s School of Medicine.


Story Source:

The above story is based on materials provided by University Of Michigan Health System. Note: Materials may be edited for content and length.


Cite This Page:

University Of Michigan Health System. "Parasite Or Partner? Study Suggests New Role For Junk DNA." ScienceDaily. ScienceDaily, 15 May 2002. <www.sciencedaily.com/releases/2002/05/020514075447.htm>.
University Of Michigan Health System. (2002, May 15). Parasite Or Partner? Study Suggests New Role For Junk DNA. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2002/05/020514075447.htm
University Of Michigan Health System. "Parasite Or Partner? Study Suggests New Role For Junk DNA." ScienceDaily. www.sciencedaily.com/releases/2002/05/020514075447.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins